PricewaterhouseCoopers' Review of the Office of National Drug Control Policy
GGD-00-170R
Published: Jun 26, 2000. Publicly Released: Jun 26, 2000.
Skip to Highlights
Highlights
Pursuant to a legislative requirement, GAO reviewed PricewaterhouseCoopers' (PwC) assessment of the performance, efficiency, and effectiveness of the Office of National Drug Control Policy's (ONDCP) operations, focusing on whether: (1) ONDCP performs its statutory and regulatory responsibilities in an efficient, effective, and results-oriented manner; (2) ONDCP optimizes human resources in fulfilling its primary objectives of policy, anti-drug program coordination, and compliance; and (3) ONDCP's internal control systems are strategically deployed to enhance business processes throughout the organization.
Full Report
Office of Public Affairs
Topics
Agency missionsFinancial management systemsStaff utilizationInternal auditsInternal controlsPerformance measuresPersonnel managementStrategic planningFinancial managementLaw enforcement